Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics-Reference-Cited by-同舟云学术

Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics

Published:2022-10-27 Issue:1 Volume:3 Page:34-49
ISSN:2730-583X
Container-title:Phenomics
language:en
Short-container-title:Phenomics

Author:

Peng Liyuan^ORCID,Song Ziping,Zhao Chengcheng,Abuduwufuer Kudusi,Wang Yanwen,Wen Zheng,Ni Li,Li Chenze,Yu Ying,Zhu Yi,Jiang Hualiang,Shen Jinshan,Jiang Xiangrui,Chen Chen,Zhang Xu,Wang Dao Wen

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s43657-022-00069-8.pdf

Reference63 articles.

1. Abraham WT, Lindenfeld J, Ponikowski P, Agostoni P, Butler J, Desai AS, Filippatos G, Gniot J, Fu M, Gullestad L, Howlett JG, Nicholls SJ, Redon J, Schenkenberger I, Silva-Cardoso J, Störk S, Krzysztof Wranicz J, Savarese G, Brueckmann M, Jamal W, Nordaby M, Peil B, Ritter I, Ustyugova A, Zeller C, Salsali A, Anker SD (2021) Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. Eur Heart J 42(6):700–710. https://doi.org/10.1093/eurheartj/ehaa943

2. Ai D, Fu Y, Guo D, Tanaka H, Wang N, Tang C, Hammock BD, Shyy JY, Zhu Y (2007) Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci USA 104(21):9018–9023. https://doi.org/10.1073/pnas.0703229104

3. Alaeddine LM, Harb F, Hamza M, Dia B, Mogharbil N, Azar NS, Noureldein MH, El Khoury M, Sabra R, Eid AA (2021) Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats. Translat Res 235:85–101. https://doi.org/10.1016/j.trsl.2021.03.010

4. Alex L, Russo I, Holoborodko V, Frangogiannis NG (2018) Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol 315(4):H934-h949. https://doi.org/10.1152/ajpheart.00238.2018

5. Askari A, Thomson SJ, Edin ML, Zeldin DC, Bishop-Bailey D (2013) Roles of the epoxygenase CYP2J2 in the endothelium. Prostaglandins Other Lipid Mediat 107:56–63. https://doi.org/10.1016/j.prostaglandins.2013.02.003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids;Journal of Molecular and Cellular Cardiology;2023-12

2. Epoxyeicosatrienoic Acids Prevent Cardiac Dysfunction in Viral Myocarditis via Interferon Type I Signaling;Circulation Research;2023-10-13